Best General Drug Manufacturer Stocks to Buy Now (2024)Top general drug manufacturer stocks in 2024 ranked by overall Zen Score. See the best general drug manufacturer stocks to buy now, according to analyst forecasts for the drug manufacturers - general industry.
Industry: Drug Manufacturers - Gene...
| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL MYERS SQUIBB CO | $48.26 | -0.52% | -6.47% | -6.45% | -3.48% | -15.59% | -31.64% | -26.28% | 4.87% | -1.73% | $70.94 | $47.58 | 31.97% | 1.43% | 0.49 | 11,916,943 | 0.24% |
| JNJ | JOHNSON & JOHNSON | $144.45 | -2.13% | -5.15% | -7.85% | -10.01% | -8.30% | -12.81% | -10.97% | 4.66% | 46.28% | $175.97 | $143.39 | 17.91% | 0.74% | 0.52 | 12,682,506 | 53.51% |
| GILD | GILEAD SCIENCES INC | $67.31 | -0.65% | -3.76% | -8.12% | -21.72% | -15.01% | -19.51% | 0.66% | 4.29% | -2.84% | $87.87 | $67.19 | 23.39% | 0.19% | 0.50 | 4,974,108 | -35.48% |
| AZN | ASTRAZENECA PLC | $68.27 | -0.68% | -0.21% | 3.67% | 1.48% | 0.66% | -7.29% | 34.54% | 73.70% | 114.91% | $76.56 | $60.47 | 10.83% | 12.89% | 0.55 | 3,817,867 | -49.88% |
| SNY | SANOFI | $45.80 | -0.95% | -3.64% | -4.24% | -11.17% | -16.18% | -18.07% | -10.72% | 9.70% | -11.36% | $57.82 | $42.63 | 20.79% | 7.44% | 0.51 | 1,356,611 | -18.45% |
| GSK | GSK PLC | $39.95 | -1.36% | -2.27% | -5.20% | 0.18% | 9.21% | 6.85% | -15.34% | -20.63% | -39.49% | $43.84 | $33.33 | 8.87% | 19.86% | 0.55 | 2,419,076 | -14.04% |
| NVS | NOVARTIS AG | $93.20 | -1.28% | -2.72% | -2.84% | -13.46% | -3.76% | -4.87% | 5.89% | 17.47% | 10.41% | $108.78 | $92.19 | 14.32% | 1.10% | 0.53 | 1,563,037 | 8.39% |
| PFE | PFIZER INC | $25.69 | -0.85% | -4.07% | -7.32% | -9.29% | -22.78% | -37.62% | -33.39% | -37.22% | -14.62% | $41.33 | $25.61 | 37.84% | 0.31% | 0.56 | 28,601,820 | -16.71% |
| BIIB | BIOGEN INC | $195.15 | -0.84% | -5.51% | -11.05% | -20.73% | -27.17% | -33.21% | -27.81% | -14.68% | -33.05% | $319.76 | $194.94 | 38.97% | 0.11% | 0.83 | 871,592 | -24.45% |
| LLY | ELI LILLY & CO | $746.74 | -0.54% | -1.39% | -2.09% | 17.68% | 21.10% | 100.55% | 294.58% | 522.49% | 1,145.40% | $800.78 | $367.35 | 6.75% | 103.28% | 0.64 | 2,501,449 | 9.16% |
| AMGN | AMGEN INC | $265.64 | 0.05% | -1.75% | -1.94% | -12.47% | -7.40% | 7.08% | 3.88% | 41.26% | 129.91% | $329.72 | $211.71 | 19.43% | 25.47% | 0.63 | 2,011,346 | 16.14% |
| MRK | MERCK & CO INC | $125.06 | -0.90% | -1.30% | 2.98% | 5.54% | 20.09% | 8.74% | 61.43% | 61.24% | 122.29% | $133.10 | $99.14 | 6.04% | 26.14% | 0.51 | 5,584,381 | -10.48% |
| ABBV | ABBVIE INC | $162.54 | 0.54% | -4.47% | -8.94% | 0.66% | 10.40% | 0.84% | 50.63% | 102.64% | 237.78% | $182.89 | $130.96 | 11.13% | 24.11% | 0.58 | 4,772,201 | -12.17% |
| GRFS | GRIFOLS SA | $6.78 | 3.67% | -5.57% | 12.07% | -7.50% | -22.43% | -10.91% | -62.29% | -65.14% | -64.52% | $12.15 | $5.30 | 44.20% | 27.92% | 0.69 | 1,534,563 | 16.52% |
| AMRN | AMARIN CORP PLC | $0.90 | -2.50% | -15.47% | 7.05% | -19.28% | 10.62% | -35.54% | -82.15% | -95.13% | -44.00% | $1.49 | $0.65 | 39.66% | 37.63% | 1.19 | 811,463 | 30.18% |
| OGN | ORGANON & CO | $17.79 | 0.45% | -3.37% | -0.11% | 7.23% | 5.52% | -26.00% | N/A | N/A | N/A | $24.79 | $10.84 | 28.24% | 64.19% | 0.77 | 2,503,395 | -5.85% |
| SCLX | SCILEX HOLDING CO | $1.16 | -9.38% | -14.71% | -15.33% | -35.20% | -36.96% | -91.93% | -88.33% | N/A | N/A | $14.65 | $0.90 | 92.08% | 28.89% | 0.10 | 974,247 | -4.70% |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.